Multiplex assays Market Outlook 2029: Presents Market Insights & Depth Analysis

The global multiplex assays market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). Multiplex assays have many applications in clinical diagnostics, drug discovery & development, genomics & molecular biology, proteomics & protein analysis, and immunology & infectious disease research. They are used for detecting and quantifying biomarkers, understanding drug mechanisms, gene expression analysis, genotyping, and studying immune responses. Furthermore, the market's growth is attributed to advancements in CAR-T therapy around the globe. CAR-T therapy has proven immense potential in the treatment of certain forms of cancer. Accurate monitoring and comprehension of CAR-T cell populations is essential for improving therapeutic efficacy and patient outcomes. This assay's capacity to completely rapidly quantify CAR-T cells can improve therapy monitoring and decision-making in clinical settings. For instance, in June 2023, Navigate BioPharma Services, Inc., launched new multiplex digital PCR assays for comprehensive quantification of multiple chimeric antigen receptor (CAR) T cells, CAR-T therapy is a form of cancer immunotherapy that uses genetically modified T cells to recognize and fight certain kinds of cancer. The multiplex digital PCR assay can measure the number, function and persistence of CAR-T cells quickly and accurately, detecting as low as 0.01%. It can be done in less than two hours, without requiring a standard curve.

Furthermore, FluoroType mycobacteria is a multiplex assay that allows for the diagnosis of multiple pathogens in a single sample, that is beneficial in terms of time and resources. This advanced diagnostic capability is especially desired in the management of tuberculosis and mycobacterial infections. For instance, in April 2022, Bruker Launched Unique LiquidArray Multiplex PCR Assays. The FluoroCycler XT thermocycler with high precision. FluoroType Mycobacteria employs innovative LiquidArray technology to distinguish 31 clinically significant non-tuberculous mycobacteria and the M. tuberculosis complex from cultures in a single test. It adds to company's extensive portfolio in tuberculosis (TB) and mycobacteria, that incorporates identification, differentiation, and drug resistance testing.

To Request a Sample of our Report on Multiplex assays Market: https://www.omrglobal.com/request-sample/multiplex-assays-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2023-2030

Segment Covered-

· By Type

· By Technology

· By End-User

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- includes Bio-Rad Laboratories, Inc., Merck Group, PerkinElmer U.S. LLC, Quansys Biosciences Inc., Thermo Fisher Scientific Inc., among others.

Multiplex assays Market Report Segment

By Type

• Protein Multiplex Assays

• Nucleic Acid-Based Multiplex Assays

• Cell-Based Multiplex Assays

By Technology

• Multiplex Real-Time PCR

• Luminex Bead Technology

• Flow Cytometry

• Others (Next-Generation Sequencing (NGS), and Microarray Technology)

By End-User

• Pharmaceutical and Biopharmaceutical Companies

• Contract Research Organizations (CROs)

• Research and Academic Institutions

• Others (Biotechnology and Pharmaceutical Companies, and Clinical Diagnostics Labs)

A full Report of Multiplex assays Market is Available @ https://www.omrglobal.com/industry-reports/multiplex-assays-market

Multiplex assays Market Report Segment by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

• Latin America

• Middle East and Africa

Company Profiles

• Bio-Rad Laboratories, Inc.

• Bio-Techne Corp.

• BioTools Inc.

• CareDx, Inc.

• Diasorin S.p.A.

• Hologic, Inc.

• Illumina, Inc.

• Merck Group

• Meso Scale Diagnostics, LLC

• PerkinElmer U.S. LLC

• Promega Corp.

• QIAGEN GmbH

• Quansys Biosciences Inc.

• Randox Laboratories

• Seegene, Inc.

• Thermo Fisher Scientific Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/multiplex-assays-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.